Bruce K. Crowther's most recent trade in Methode Electronics, Inc. was a trade of 18,543 Common Stock done at an average price of $8 . Disclosure was reported to the exchange on Sept. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Methode Electronics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 8.00 per share. | 16 Sep 2025 | 18,543 | 50,654 (0%) | 0% | 8 | 148,344 | Common Stock |
| Methode Electronics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 9.88 per share. | 13 Jun 2024 | 14,170 | 32,111 (0%) | 0% | 9.9 | 140,000 | Common Stock |
| Neogenomics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 11,336 | 11,336 | - | - | Restricted Stock Unit | |
| Neogenomics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,353 | 8,353 | - | - | Stock Option (Right to Buy) | |
| Methode Electronics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 33.33 per share. | 05 Jul 2023 | 4,201 | 17,941 (0%) | 0% | 33.3 | 140,019 | Common Stock |
| Wintrust Fin Corp | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 81.55 per share. | 31 Dec 2022 | 686 | 44,545 (0%) | 0% | 81.5 | 55,943 | Common Stock |
| Wintrust Fin Corp | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 80.15 per share. | 30 Sep 2022 | 695 | 43,859 (0%) | 0% | 80.1 | 55,704 | Common Stock |
| Methode Electronics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 36.04 per share. | 07 Jul 2022 | 3,885 | 13,740 (0%) | 0% | 36.0 | 140,015 | Common Stock |
| Wintrust Fin Corp | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 92.93 per share. | 30 Jun 2022 | 598 | 43,164 (0%) | 0% | 92.9 | 55,572 | Common Stock |
| Neogenomics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,556 | 65,120 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 13,882 | 13,882 | - | - | Stock Option (Right to Buy) | |
| Wintrust Fin Corp | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 90.82 per share. | 31 Mar 2022 | 609 | 42,566 (0%) | 0% | 90.8 | 55,309 | Common Stock |
| Wintrust Fin Corp | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 75.63 per share. | 30 Sep 2021 | 627 | 41,364 (0%) | 0% | 75.6 | 47,420 | Common Stock |